Quick Answer
PHIBRO ANIMAL HEALTH CORP reported Revenue (ASC 606) of $1.30 billion for fiscal year 2025.
PHIBRO ANIMAL HEALTH CORP Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $1.30B | +27.4% |
| 2024 | $1.02B | +4.1% |
| 2023 | $977.89M | +3.8% |
| 2022 | $942.26M | +13.1% |
| 2021 | $833.35M | +4.1% |
| 2020 | $800.35M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $373.91M | +20.9% | +2.8% |
| September 30, 2025 | $363.89M | +39.7% | +4.6% |
| March 31, 2025 | $347.82M | +32.1% | +12.5% |
| December 31, 2024 | $309.26M | +23.7% | +18.7% |
| September 30, 2024 | $260.43M | +12.6% | -1.1% |
| March 31, 2024 | $263.22M | +7.1% | +5.3% |
| December 31, 2023 | $249.94M | +2.2% | +8.0% |
| September 30, 2023 | $231.35M | -0.5% | -5.8% |
- PHIBRO ANIMAL HEALTH CORP showed an increase of +27.4% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2020–2025 period, PHIBRO ANIMAL HEALTH CORP’s revenue (asc 606) has grown by 62.0% (from $800.35 million to $1.30 billion).
- The most recent figure is from PHIBRO ANIMAL HEALTH CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: